Trial record 6 of 70 for:    Open Studies | "Urticaria"

Development of an Urticaria Control Test (UCT-D)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified February 2013 by Charite University, Berlin, Germany.
Recruitment status was  Recruiting
Information provided by (Responsible Party):
K. Weller, Charite University, Berlin, Germany Identifier:
First received: May 30, 2012
Last updated: February 14, 2013
Last verified: February 2013

The aim of the project is to develop a patient reported outcome instrument to assess disease control in chronic urticaria patients (Urticaria Control Test - UCT) of age 12 and older.

Chronic Urticaria

Study Type: Observational
Study Design: Time Perspective: Prospective
Official Title: UCT - Development of an Instrument to Assess Disease Control in Patients With Chronic Urticaria (Urticaria Control Test)

Resource links provided by NLM:

Further study details as provided by Charite University, Berlin, Germany:

Estimated Enrollment: 300
Study Start Date: October 2011
Estimated Study Completion Date: August 2013
Estimated Primary Completion Date: June 2013 (Final data collection date for primary outcome measure)
chronic urticaria patients
all patients suffering from chronic types of urticaria (chronic spontaneous urticaria as well as chronic inducible forms such as cold contact urticaria)


Ages Eligible for Study:   12 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

all patients suffering from chronic forms of urticaria


Inclusion Criteria:

all patients suffering from chronic forms of urticaria are eligible

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01610128

Contact: Karsten Weller, MD

Universitätshautklinik Mainz Recruiting
Mainz, Rheinland-Pfalz, Germany, 55131
Contact: Petra Staubach, MD   
Principal Investigator: Petra Staubach, MD         
Allergie-Centrum-Charite Recruiting
Berlin, Germany, 10117
Contact: Karsten Weller, MD   
Contact: Marcus Maurer, MD   
Principal Investigator: Karsten Weller, MD         
Sponsors and Collaborators
Charite University, Berlin, Germany
  More Information

No publications provided

Responsible Party: K. Weller, Principal Investigator, Charite University, Berlin, Germany Identifier: NCT01610128     History of Changes
Other Study ID Numbers: UCT-D
Study First Received: May 30, 2012
Last Updated: February 14, 2013
Health Authority: Germany: Ethics Commission

Keywords provided by Charite University, Berlin, Germany:
urticaria, patient reported outcome

Additional relevant MeSH terms:
Hypersensitivity, Immediate
Immune System Diseases
Skin Diseases
Skin Diseases, Vascular processed this record on October 07, 2015